David Joyner is an American business executive. He is the president and chief executive officer of CVS Health.[1][2][3]

Joyner is the former president of CVS Caremark and replaced Karen S. Lynch as president and CEO of CVS Health.[4]

Life and career

[edit]

Joyner received a BBA in finance from Texas Tech University in 1986.[5]

He first worked at Aetna before joining CVS Caremark, eventually becoming president of the company.[5] In April 2024, he wrote an article for Fortune about pharmacy benefit management.[6]

In July 2024, he testified before the United States House Committee on Oversight and Accountability about pharmacy benefit managers and perscription drug markets.[7]

In October 2024, Joyner became the president and chief executive officer of CVS Health, along with joining the board of directors.[8] He replaced Karen S. Lynch.[4] Investor pressure after poor company financials was cited as one of the causes for the change in CVS Health's leadership.[9]

He is on the advisory council of the Rawls College of Business.[5]

References

[edit]
  1. ^ Tulfo, Erika (18 October 2024). "CVS names new CEO in the wake of layoffs and poor stock performance". cnn.com. CNN. Retrieved 20 October 2024.
  2. ^ Roy, Sriparna; Leo, Leroy (19 October 2024). "CVS names Joyner as CEO under investor pressure, withdraws profit forecast". reuters.com. Reuters. Retrieved 20 October 2024.
  3. ^ "CVS Health CEO Karen Lynch steps down, replaced by David Joyner, after 19% stock plunge". cbsnews.com. CBS News. 18 October 2024. Retrieved 20 October 2024.
  4. ^ a b https://rhodeislandcurrent.com/2024/10/18/cvs-health-is-hurting-will-a-new-ceo-cure-its-financial-ills/
  5. ^ a b c https://www.depts.ttu.edu/rawlsbusiness/advisory-council/david-joyner/
  6. ^ https://fortune.com/2024/04/03/time-for-facts-in-the-pbm-debate/
  7. ^ https://oversight.house.gov/wp-content/uploads/2024/08/Letter-to-Joyner-FINAL-re-PBM-Hearing-Testimony.pdf
  8. ^ https://www.cnbc.com/2024/10/18/cvs-to-replace-ceo-karen-lynch-with-exec-david-joyner.html
  9. ^ https://www.reuters.com/business/healthcare-pharmaceuticals/cvs-name-long-time-exec-david-joyner-new-ceo-wsj-reports-2024-10-18/
[edit]